Study and Treatment of Oral Squamous Cell Carcinoma—Insights and Perspectives
1
Department of Oral and Maxillofacial Surgery, Head and Neck Cancer Center, University Hospital Schleswig-Holstein (Campus Lübeck), D-23562 Luebeck, Germany
2
Department of Oral and Maxillofacial Surgery, Helios Medical Center, D-19055 Schwerin, Germany
3
Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong
*
Author to whom correspondence should be addressed.
Cancers 2023, 15(20), 4968; https://doi.org/10.3390/cancers15204968
Submission received: 23 September 2023
/
Revised: 30 September 2023
/
Accepted: 10 October 2023
/
Published: 13 October 2023
(This article belongs to the Special Issue Study and Treatment of Oral Squamous Cell Carcinoma)
The prevalence of oral squamous cell carcinoma (OSCC) has increased in recent decades, and its impact on the health system has become a new aspect. In addition to the well-known exogenous noxae like nicotine and alcohol consumption, as well as some distinct nutritional habits such as betel nut chewing and virus infection by the human papilloma virus (HPV), its transfer via sexual practices augmented the recent increase in the incidence of oropharyngeal cancer [1]. Finally, the development and establishment of immune-suppressive treatments for autoimmune diseases and in patients with organ transplants enhanced the potential development of OSCC in precursor lesions. Currently, we are dealing with more than 377,000 new cases and 177,000 deaths related to lip and oral cavity tumors worldwide in 2020, according to the Global Cancer Observatory report.
In parallel, our understanding of the initiation and development of oral cancer has also changed substantially. The molecular basis for the epithelial invasion mechanisms, including the epithelial–mesenchymal transition (EMT) and remodeling of the extracellular matrix (ECM), not only intensified our knowledge concerning the underlying pathology but also brought more sophisticated diagnostic methods and prognostic tools, as well as promising therapeutic options for patients with OSSC [2,3,4].
The original research and review articles included in this Special Issue elucidate the diversity of molecular mechanisms involved in the onset, invasion, and progression of OSCC, with particular attention paid to the role of HPV infection and multimodal treatment. Finally, a state-of-the-art review of modern 3D-based microsurgical reconstruction following ablative oncologic surgery of the head and neck region enriches the scope of this Special Issue [5,6]. These articles highlight special aspects in the diagnosis and treatment of OSCC and provide an orientation in the management of patients with OSCC in terms of diagnosis, patient care, and quality of life.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Mylly, M.; Nissi, L.; Huusko, T.; Routila, J.; Vaittinen, S.; Irjala, H.; Leivo, I.; Ventela, S. Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005–2015 in a Representative Northern European Population. Cancers 2022, 14, 5717. [Google Scholar] [CrossRef] [PubMed]
- Berndt, A.; Gassler, N.; Franz, M. Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin gamma2 Chain in Tumor Biology, Diagnosis, and Therapy. Cancers 2022, 14, 4903. [Google Scholar] [CrossRef] [PubMed]
- Nisar, S.; Yousuf, P.; Masoodi, T.; Wani, N.A.; Hashem, S.; Singh, M.; Sageena, G.; Mishra, D.; Kumar, R.; Haris, M.; et al. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int. J. Mol. Sci. 2021, 22, 4584. [Google Scholar] [CrossRef] [PubMed]
- Freiser, M.E.; Serafini, P.; Weed, D.T. The immune system and head and neck squamous cell carcinoma: From carcinogenesis to new therapeutic opportunities. Immunol. Res. 2013, 57, 52–69. [Google Scholar] [CrossRef] [PubMed]
- Pu, J.J.; Hakim, S.G.; Melville, J.C.; Su, Y.X. Current Trends in the Reconstruction and Rehabilitation of Jaw following Ablative Surgery. Cancers 2022, 14, 3308. [Google Scholar] [CrossRef] [PubMed]
- Knitschke, M.; Yonan, M.; Roller, F.C.; Pons-Kuhnemann, J.; Attia, S.; Howaldt, H.P.; Streckbein, P.; Bottger, S. Osseous Union after Jaw Reconstruction with Fibula-Free Flap: Conventional vs. CAD/CAM Patient-Specific Implants. Cancers 2022, 14, 5774. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Hakim, S.G.; Su, Y.-X. Study and Treatment of Oral Squamous Cell Carcinoma—Insights and Perspectives. Cancers 2023, 15, 4968. https://doi.org/10.3390/cancers15204968
AMA Style
Hakim SG, Su Y-X. Study and Treatment of Oral Squamous Cell Carcinoma—Insights and Perspectives. Cancers. 2023; 15(20):4968. https://doi.org/10.3390/cancers15204968
Chicago/Turabian StyleHakim, Samer George, and Yu-Xiong (Richard) Su. 2023. "Study and Treatment of Oral Squamous Cell Carcinoma—Insights and Perspectives" Cancers 15, no. 20: 4968. https://doi.org/10.3390/cancers15204968
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
